Antiviral Drug Resistance Market is witnessing significant global growth driven by the rising prevalence of viral infections and the increasing emergence of drug-resistant viral strains. The growing burden of diseases such as HIV, influenza, hepatitis, and herpes has intensified the need for more effective antiviral therapies, as traditional treatment options are gradually losing efficacy due to viral mutation and resistance development.The Antiviral Drug Resistance Market is further supported by the continuous evolution of viruses, which adapt rapidly and reduce the effectiveness of existing antiviral drugs. This has created a strong demand for novel drug discovery, combination therapies, and advanced diagnostic solutions that can detect resistance patterns early and guide personalized treatment approaches. The expansion of global healthcare infrastructure and increased investment in infectious disease research are also accelerating market development.
Market Drivers:
Rising prevalence of chronic and acute viral infections
Increasing incidence of antiviral drug-resistant strains
Growth in research and development of novel antiviral therapies
Related Report:
Vertebroplasty Kyphoplasty Market
Edwards Syndrome Treatment Market
Multi Use Diamond Bur Market
Plasma Expressor Machine Market
Monoclonal Antibody Custom Service Market
Anthrax Treatment Market
Dermatoscope Market